BridgeBio Oncology Therapeutics, Inc. (BBOT) Misses Q2 EPS by 70468c

BridgeBio Oncology Therapeutics, Inc. (NASDAQ: BBOT) reported Q2 EPS of ($705.20), $704.68 worse than the analyst estimate of ($0.52).

For earnings history and earnings-related data on BridgeBio Oncology Therapeutics, Inc. (BBOT) click here.

You May Also Be Interested In

• UBS Starts Kalyan Jewellers India Ltd (KALYANKJ:IN) at Buy
• BetterLife Pharma files final prospectus for $100M public offering
• Boeing wins $13.4 billion contract modification from US military